⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 24, 2013Breast Cancer ResearchOpen Access

Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort

Ashley C. Godfrey Zongli Xu Clarice R. Weinberg Robert Getts Paul A. Wade Lisa A. DeRoo Dale P. Sandler Jack A. Taylor

View Full Paper

Ask AI

Bookmark

Share

Abstract

This is the authors' abstract. We don't add key points for this paper.

miRNA levels in serum show a number of small differences between women who later develop cancer versus those who remain cancer-free.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Godfrey et al. (2013) studied this question.

synapsesocial.com/papers/69de6b94a051b8e25be94019 https://doi.org/10.1186/bcr3428

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer BiomarkersOriginal Research · 2013 · 282 citations
2Evaluation of Micro-RNA Expression Profiling Level as Biomarkers for Diagnosis and Gene Sequencing in Patients Suffering from Breast Cancer2024
3Cancer‐specific risk prediction with a serum <scp>microRNA</scp> signature2024 · 2 citations
4Circulating microRNAs as Early Biomarkers of Breast Cancer: A Nested Case-Control Study Within a Prospective Cohort in ItalyCohort Study · 2026
5Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancerCase-Control Study · 2018 · 75 citations
6Exploratory Analysis of Circulating Serum miR-197-3p, miR-1236, and miR-1271 Expression in Early Breast Cancer2025 · 2 citations
7Multicenter development and validation of a serum microRNA–based diagnostic model for breast cancer and its association with tumor burden and biological aggressiveness: an observational case-control studyCase-Control Study · 2026
8Circulating microRNAs and serum proteins in breast cancer patients: Diagnostic relevance and grade-specific expression patterns2025 · 3 citations
9Integrative analysis of DCE-MRI radiomics and genomics reveals complementary characterization of treatment response–associated tumor vascular heterogeneity in breast cancerBreast Cancer Research · 2026
10Culmerciclib plus endocrine therapy as first-line treatment in patients with HR+/HER2- advanced breast cancer: a single-arm, phase 2 trialBreast Cancer Research · 2026

More from Breast Cancer Research

More from National Institutes of Health

More from National Institute of Environmental Health Sciences

More from Sphere Institute